News tagged with regimen
Lecture or listen: When patients waver on meds
Take your medicine, Doctor's orders. It's a simple idea that may seem especially obvious when the pills are the antiretroviral (ARV) drugs that add decades to the lives of HIV-positive patients. But despite the reality that ...
Medicine & Health / HIV & AIDS
Feb 02, 2012 |
not rated yet |
0
Stop taking steroids: Kidney transplant recipients may not need long-term prednisone
Rapid discontinuation of the immunosuppressive steroid prednisone after a kidney transplant can help prevent serious side effects, according to a study appearing in an upcoming issue of the Clinical Journal of the American So ...
Jan 26, 2012 |
not rated yet |
0
Drug improves survival of colorectal cancer patients, trial results show
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Jan 18, 2012 |
not rated yet |
0
Studies help clarify the role of lapatinib and trastuzumab in treating HER2 positive breast cancer
In patients with HER2-positive breast cancer, Tykerb (lapatinib) has been used both in combination with herceptin (trastuzumab) and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy treatment. ...
Jan 16, 2012 |
5 / 5 (2) |
0
|
An inside look at face transplantation
In March 2011, a surgical team at Brigham and Women's Hospital (BWH) performed the first full face transplantation (FFT) in the United States and went on to complete a total of three FFTs this year. Now, in ...
Dec 28, 2011 |
not rated yet |
0
|
Autologous stem cell transplantation does not improve os in patients with follicular lymphoma
High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy ...
Dec 21, 2011 |
not rated yet |
0
RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer
Over 17,000 patients will have been diagnosed with locally-advanced pancreatic cancer in the United States in 2011. Surgery is not a treatment option for these patients whose tumor has grown beyond the pancreas to surrounding ...
Dec 14, 2011 |
5 / 5 (2) |
0
Study finds superior drug combo for difficult-to-control epilepsy
A combination of two common drugs, lamotrigine and valproate, is more effective in treating difficult-to control epilepsy than other anti-epileptic regimens, according to a University of Washington report to be published ...
Medicine & Health / Neuroscience
Dec 14, 2011 |
not rated yet |
0
|
Survival rates increase with chemotherapy alone in patients with limited-stage Hodgkin's lymphoma
New research led by the NCIC Clinical Trials Group (CTG) at Queen's University has proven patients with limited stage Hodgkin's lymphoma have a better chance of long-term survival if they undergo a standard chemotherapy regimen ...
Dec 12, 2011 |
5 / 5 (1) |
0
US urges shorter treatment for TB
US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.
Dec 08, 2011 |
not rated yet |
0
Research finds many women not receiving recommended breast cancer adjuvant treatment
A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment ...
Dec 06, 2011 |
not rated yet |
0
South Africa unveils plan to halve HIV infections
President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.
Medicine & Health / HIV & AIDS
Dec 01, 2011 |
not rated yet |
0
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Nov 24, 2011 |
not rated yet |
0
Study identifies possible therapy for radiation sickness
A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists ...
Nov 23, 2011 |
4.8 / 5 (6) |
3
|
New TB treatment limits infection while reducing drug resistance
It's estimated that nearly one-third of the world's population -- more than two billion people -- are infected with Mycobacterium tuberculosis. According to the World Health Organization, 5 to 10 percent of infected people ...
Nov 16, 2011 |
not rated yet |
0
